Psychological Support and Psycho-Emotional Trajectories in Cancer Genetics.

Sponsor
Assistance Publique - Hôpitaux de Paris
Study ID
NCT07695506
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Genetic Testing
  • Hereditary Neoplastic Syndromes
  • Neoplasms
  • Psychological Distress

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Patients undergoing their first cancer genetic testing consultation who choose to utilise the clinical psychological support offered by the unit — OTHER
    This includes structured clinical interviews with the unit's psychologist within 15 days following the initial consultation (T1), 15 days following result disclosure (T2), and 2.5 months post-disclosure. Patients can change their choice at any point if their support needs change.
  • Patients undergoing their first cancer genetic testing consultation who choose to follow the care pathway without utilising the systematically offered clinical psychological support. — OTHER
    To ensure equity of care, these patients maintain the right to request and access the psychological support program at any time during their pathway if their needs change.

Study Details

Undergoing a cancer genetic testing pathway and receiving results regarding a personal or familial cancer predisposition can generate substantial, multifaceted psycho-emotional distress for patients. While professional psychological support is strongly recommended in clinical guidelines, very few studies have formally quantified its actual contribution to the longitudinal psycho-emotional experiences of patients within real-world clinical practices. The primary objective of the PsyOncoGen study is to describe the longitudinal psycho-emotional trajectories of patients within the routine care pathway. It evaluates the clinical impact of psychological support by observing the natural outcomes of patients who choose to accept this systematically offered service versus those who choose to decline it. The study will follow 220 adult patients across two natural cohorts determined solely by patient choice: 110 patients utilising the clinical psychological support and 110 patients declining it.

Key Dates

First listed
Jul 10, 2026
Start date
Sep 1, 2026
Status verified
Jul 2026
Primary completion
Jun 1, 2028
Completion
Jun 1, 2028

Study Design

Enrollment
220 participants (estimated)

Arms

  • Arm: Psychological Support Group
  • Arm: Group Without Psychological Support

Primary Outcome Measure

Longitudinal study of Psycho-Emotional Distress Scores [ Time Frame: Up to 9 months ]

Central Contacts

Related Studies